IP Library Patent Application 13085302
Patent Application
App. No. 13/085,302

PRODUCTS AND METHODS FOR TISSUE PRESERVATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/085,302
Abstract

The present application relates to methods for increasing stability of formalin fixed, optionally paraffin embedded biological material. In one example, DNAse inhibitors and/or RNAse inhibitors are combined with the biological material or formalin at the time of fixation or shortly prior.

Claims (43)

1 . A composition comprising:

a. a degradation inhibitor, and

b. formalin.

2 . The composition of claim 1 wherein the formalin is phosphate buffered at between 1-37% by mass.

3 . The composition of claim 1 further comprising a solid tissue sample.

4 . (canceled)

5 . The composition of claim 1 wherein the degradation inhibitor comprises a small molecule inhibitor of the phosphoryl transferase superfamily.

6 .- 12 . (canceled)

13 . The composition of claim 1 wherein the degradation inhibitor a reactive oxygen species scavenger.

14 .- 16 . (canceled)

17 . A composition comprising:

a. a small molecule inhibitor of the phosphoryl transferase superfamily, and

b. a reactive oxygen species scavenger.

18 .- 20 . (canceled)

21 . A method for preserving a polynucleotide in a biologic sample comprising:

a. contacting the biologic sample with formalin,

b. contacting the biologic sample with a degradation inhibitor.

22 . The method of claim 21 wherein the contacting the biologic sample with formalin is performed at a temperature between 1° C. and 6° C. or at room temperature.

23 . The method of claim 21 wherein the formalin has a pH in the range of 3 to 10.

24 . The method of claim 21 wherein the degradation inhibitor comprises a small molecule inhibitor of the phosphoryl transferase superfamily.

25 . The method of claim 24 wherein the small molecule inhibitor comprises one or more of (Table 1).

26 . The method of claim 21 wherein the degradation inhibitor comprises a water-soluble reactive oxygen species scavenger.

27 . The method of claim 26 wherein the water-soluble reactive oxygen species scavenger comprises one or more of (table 2).

28 . The method of claim 21 wherein the degradation inhibitor comprises a small molecule inhibitor of the phosphoryl transferase superfamily and a water-soluble reactive oxygen species scavenger.

29 . The method of claim 28 wherein the small molecule inhibitor comprises one or more of (Table 1) and wherein the water-soluble reactive oxygen species scavenger comprises one or more of (table 2).

30 . A method for analyzing a polynucleotide comprising

a. obtaining a biologic sample, wherein the sample has been contacted with formalin solution, contacted with a degradation inhibitor, dehydrated, embedded, and stored;

b. purifying the polynucleotide, and

c. analyzing the polynucleotide.

31 .- 45 . (canceled)

46 . A formalin fixed paraffin embedded tissue containing a plurality of polynucleotides wherein at least 5% of the polynucleotides strands are greater than 300 base pairs.

47 . A polynucleotide recovered from fixed tissue:

a. wherein the polynucleotide strand is at least 300 base pairs,

b. wherein the tissue was fixed in formalin,

c. wherein the formalin comprises a degradation inhibitor.

d. wherein the fixed tissue was embedded in paraffin.

48 .- 53 . (canceled)

54 . A polynucleotide recovered from fixed tissue:

a. wherein the polynucleotide strand is at least 300 base pairs,

b. wherein the tissue was fixed in formalin,

c. wherein the tissue was washed in a ethanol-water wash comprising a water-soluble reactive oxygen species scavenger, and

d. wherein the fixed tissue was embedded in paraffin.

55 . The polynucleotide of claim 54 wherein the reactive oxygen species scavenger comprises one or more of (Table 2).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2014
From: INTEGENX, INC.
To: GENTEGRA LLC
Reel/Frame 032117/0260 →
MERGER Recorded Mar 13, 2013
From: GENVAULT CORPORATION
To: INTEGENX INC.
Reel/Frame 029989/0708 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2011
From: HOGAN, MICHAEL
To: GENVAULT CORPORATION
Reel/Frame 026644/0164 →